SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

JPMorgan Raises BeOne Medicines Price Target to $460 From $445

Valid market news retained in the public archive without immediate LiveCast distribution.

ONC

Related stories